The Investor With Joel Palathinkal
The Investor with Joel Palathinkal is a global omni channel show which highlights institutional investors from all walks of life and supports the continuing education for the next generation of allocators
Nathan Lian: Pareto VC
Joel Palathinkal explores the intersection of AI and biotech with Nathan Lian from Pareto VC. Nathan discusses his career journey and investment strategies in deep tech and biotech. They delve into AI's role in drug discovery, lab experiments, and the PH fellowship's goals and selection process. The conversation highlights opportunities in synthetic biology, longevity, health tech, and behavioral psychology. They also address challenges in real-time health data and continuous monitoring, emphasizing user experience in health predictive analytics. This episode offers a comprehensive look at the future of biotech investments.
Key Points
- Investing in deep tech and biotech, particularly in AI and robotics, is seen as a compelling way to gain a competitive edge and make a significant impact on health and wellness.
- PhD students and postdocs are an untapped resource for founding biotech startups, as they possess the grit and creativity from their daily experiments but often lack commercial acumen, which can be coached.
- There is a significant opportunity in developing seamless, non-invasive ways to continuously monitor health data and provide actionable insights, leveraging technologies like computer vision and behavioral psychology to improve long-term health outcomes.
Chapters
| 0:00 | |
| 0:51 | |
| 4:39 | |
| 7:02 | |
| 10:17 | |
| 15:42 | |
| 20:40 | |
| 25:28 | |
| 29:24 | |
| 34:41 | |
| 37:02 |
Transcript
Loading transcript...
- / -